Aleksandras Laucevičius1, Egidija Rinkūnienė2, Žaneta Petrulionienė3, Ligita Ryliškytė1, Agnė Jucevičienė3, Roma Puronaitė4, Jolita Badarienė3, Rokas Navickas5, Jurgita Mikolaitytė6, Urtė Gargalskaitė3, Vilma Dženkevičiūtė3, Sandra Kutkienė3, Silvija Gimžauskaitė5, Antanas Mainelis7, Rimvydas Šlapikas8, Romas Gurevičius9, Dalius Jatužis3, Vytautas Kasiulevičius3. 1. Faculty of Medicine, Vilnius University, Vilnius, Lithuania; Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania; State Research Institute Centre of Innovative Medicine, Vilnius, Lithuania. 2. Faculty of Medicine, Vilnius University, Vilnius, Lithuania; Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania. Electronic address: egidija.rinkuniene@santa.lt. 3. Faculty of Medicine, Vilnius University, Vilnius, Lithuania; Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania. 4. Faculty of Medicine, Vilnius University, Vilnius, Lithuania; Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania; Faculty of Mathematics and Informatics, Vilnius University, Vilnius, Lithuania. 5. Faculty of Medicine, Vilnius University, Vilnius, Lithuania. 6. State Research Institute Centre of Innovative Medicine, Vilnius, Lithuania. 7. Faculty of Mathematics and Informatics, Vilnius University, Vilnius, Lithuania. 8. Lithuanian University of Health Sciences, Kaunas, Lithuania. 9. Institute of Hygiene, Vilnius, Lithuania.
Abstract
BACKGROUND AND AIMS: The aim of the study was to estimate trends and differences in cardiovascular disease (CVD) risk factor prevalence among middle-aged men and women based on the data from the Lithuanian High Cardiovascular Risk (LitHiR) primary prevention program between 2009 and 2018. METHODS: A community-based cross-sectional study included men aged 40-54 years and women aged 50-64 years without overt CVD. Nationally representative data comprised 110,370 Lithuanian adults (42.4% men and 57.6% women) examined in the period 2009-2018. Prevalences of major CVD risk factors, such as dyslipidaemia, arterial hypertension, diabetes mellitus, obesity, metabolic syndrome and smoking, were assessed. RESULTS: The study showed a significant drop in the prevalence of dyslipidaemia and TC levels among men (p = 0.030 and p < 0.001) and no significant change among women (p = 0.594 and p = 0.799). The prevalence of AH significantly decreased in both gender groups (p < 0.001 in women and p < 0.001 in men). Obesity rates declined among women while it remained constant among men (p < 0.001 and p = 0.100 respectively). There was a significant decline among women and a significant increase among men in the prevalence of metabolic syndrome (p < 0.001 and p = 0.016 respectively). The prevalence of diabetes increased until 2013, after which it started decreasing in the whole group (p = 0.005). The study showed a significant increase in the percentage of smoking women (p < 0.001), although the number of smoking men remained much higher (about 40%) (p < 0.001). CONCLUSIONS: In our observational study, we have documented a high prevalence of all CVD risk factors in 2009 with a slight decrease during the period in most prevalence rates, except in dyslipidaemia and smoking levels.
BACKGROUND AND AIMS: The aim of the study was to estimate trends and differences in cardiovascular disease (CVD) risk factor prevalence among middle-aged men and women based on the data from the Lithuanian High Cardiovascular Risk (LitHiR) primary prevention program between 2009 and 2018. METHODS: A community-based cross-sectional study included men aged 40-54 years and women aged 50-64 years without overt CVD. Nationally representative data comprised 110,370 Lithuanian adults (42.4% men and 57.6% women) examined in the period 2009-2018. Prevalences of major CVD risk factors, such as dyslipidaemia, arterial hypertension, diabetes mellitus, obesity, metabolic syndrome and smoking, were assessed. RESULTS: The study showed a significant drop in the prevalence of dyslipidaemia and TC levels among men (p = 0.030 and p < 0.001) and no significant change among women (p = 0.594 and p = 0.799). The prevalence of AH significantly decreased in both gender groups (p < 0.001 in women and p < 0.001 in men). Obesity rates declined among women while it remained constant among men (p < 0.001 and p = 0.100 respectively). There was a significant decline among women and a significant increase among men in the prevalence of metabolic syndrome (p < 0.001 and p = 0.016 respectively). The prevalence of diabetes increased until 2013, after which it started decreasing in the whole group (p = 0.005). The study showed a significant increase in the percentage of smoking women (p < 0.001), although the number of smoking men remained much higher (about 40%) (p < 0.001). CONCLUSIONS: In our observational study, we have documented a high prevalence of all CVD risk factors in 2009 with a slight decrease during the period in most prevalence rates, except in dyslipidaemia and smoking levels.
Authors: Ricardas Radisauskas; Kawon Victoria Kim; Shannon Lange; Vaida Liutkute-Gumarov; Olga Mesceriakova-Veliuliene; Janina Petkeviciene; Mindaugas Stelemekas; Tadas Telksnys; Alexander Tran; Jürgen Rehm Journal: BMC Public Health Date: 2021-11-17 Impact factor: 3.295